Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Erasca Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

$ERASPress releaseAug 10, 2026, 4:01 PM ETRead the release

Erasca granted inducement awards to newly appointed President of Research and Development Dr. Charles S. Fuchs, consisting of non-qualified stock options to purchase 1.28 million shares. The grants were approved by the board under Nasdaq Listing Rule 5635(c)(4) to facilitate the employment, with 25% vesting on August 10, 2027, and the remainder vesting monthly thereafter.

Key figures

Inducement options shares
1278520

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.